Palvella Therapeutics (PVLA) Exchange Rate Effect (2014 - 2026)
Palvella Therapeutics (PVLA) posted quarterly Exchange Rate Effect of -$15000.0 for Q1 2026, down 150.0% year-over-year from $30000.0 in Q1 2025, and up 97.54% quarter-over-quarter from -$610000.0 in Q4 2025.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Exchange Rate Effect for 13 consecutive years, with -$15000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 150.0% year-over-year to -$15000.0; the TTM figure through Mar 2026 stood at $37000.0 (up 1333.33% YoY), while the FY2025 annual figure was $46000.0, up 1433.33% from the prior year.
- Exchange Rate Effect grew to -$15000.0 in Q1 2026 per PVLA's latest filing, from -$610000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.9 million in Q4 2022 and bottomed at -$3.3 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$367214.3 across 5 years, with a median of -$45000.0 in 2023.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 315.39% — and 2025, when it tumbled 20433.33%.
- Palvella Therapeutics' Exchange Rate Effect stood at $1.9 million in 2022, then plunged by 103.86% to -$75000.0 in 2023, then soared by 104.0% to $3000.0 in 2024, then sank by 20433.33% to -$610000.0 in 2025, then soared by 97.54% to -$15000.0 in 2026.
- Business Quant data shows PVLA's Exchange Rate Effect at -$15000.0 in Q1 2026, -$610000.0 in Q4 2025, and $770000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.93 Bn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -610,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Sep 30, 2023 | -337,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | -2.81 Mn |
| Jun 30, 2022 | -3.32 Mn |
| Mar 31, 2022 | -994,000.00 |
| Dec 31, 2021 | -903,000.00 |
| Sep 30, 2021 | -1.13 Mn |
| Jun 30, 2021 | -32,000.00 |
| Mar 31, 2021 | -1.13 Mn |
| Dec 31, 2020 | 2.04 Mn |